ATP Release In Response To Hypotonic Stress From Airway Epithelial Cells Is Decreased After Interferon-γ Treatment

Author(s):  
Stefanie Krick ◽  
Melissa St-Pierre ◽  
Gregory E. Conner ◽  
Matthias Salathe
2004 ◽  
Vol 31 (5) ◽  
pp. 573-582 ◽  
Author(s):  
Nicola M. Heller ◽  
Satoshi Matsukura ◽  
Steve N. Georas ◽  
Mark R. Boothby ◽  
Paul B. Rothman ◽  
...  

2012 ◽  
Vol 32 (11) ◽  
pp. 524-533 ◽  
Author(s):  
Mette Eliasson ◽  
Anders I. Olin ◽  
Johan A. Malmström ◽  
Matthias Mörgelin ◽  
Mikael Bodelsson ◽  
...  

1999 ◽  
Vol 276 (3) ◽  
pp. C700-C710 ◽  
Author(s):  
Lisa M. Schwiebert ◽  
Kim Estell ◽  
Stacie M. Propst

To delineate the mechanisms that facilitate leukocyte migration into the cystic fibrosis (CF) lung, expression of chemokines, including interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1), and RANTES, was compared between CF and non-CF airway epithelia. The findings presented herein demonstrate that, under either basal conditions or tumor necrosis factor-α (TNF-α)- and/or interferon-γ (IFN-γ)-stimulated conditions, a consistent pattern of differences in the secretion of IL-8 and MCP-1 between CF and non-CF epithelial cells was not observed. In contrast, CF epithelial cells expressed no detectable RANTES protein or mRNA under basal conditions or when stimulated with TNF-α and/or IFN-γ ( P ≤ 0.05), unlike their non-CF counterparts. Correction of the CF transmembrane conductance regulator (CFTR) defect in CF airway epithelial cells restored the induction of RANTES protein and mRNA by TNF-α in combination with IFN-γ ( P ≤ 0.05) but had little effect on IL-8 or MCP-1 production compared with mock controls. Transfection studies utilizing RANTES promoter constructs suggested that CFTR activates the RANTES promoter via a nuclear factor-κB-mediated pathway. Together, these results suggest that 1) RANTES expression is altered in CF epithelia and 2) epithelial expression of RANTES, but not IL-8 or MCP-1, is dependent on CFTR.


Toxins ◽  
2016 ◽  
Vol 8 (12) ◽  
pp. 365 ◽  
Author(s):  
Romina Baaske ◽  
Mandy Richter ◽  
Nils Möller ◽  
Sabine Ziesemer ◽  
Ina Eiffler ◽  
...  

2008 ◽  
Vol 101 (4) ◽  
pp. 533-540 ◽  
Author(s):  
Ahmad Saedisomeolia ◽  
Lisa G. Wood ◽  
Manohar L. Garg ◽  
Peter G. Gibson ◽  
Peter A. B. Wark

Long-chain n-3 PUFA (LCn-3PUFA) including DHA and EPA, are known to decrease inflammation by inhibiting arachidonic acid (AA) metabolism to eicosanoids, decreasing the production of pro-inflammatory cytokines and reducing immune cell function. The aim of this study was to determine if EPA and DHA reduced the release of inflammatory mediators from airway epithelial cells infected with rhinovirus (RV). Airway epithelial cells (Calu-3) were incubated with EPA, DHA and AA for 24 h, followed by rhinovirus infection for 48 h. IL-6, IL-8 and interferon-γ-induced protein-10 (IP-10) released by cells were measured using ELISA. Viral replication was measured by serial titration assays. The fatty acid content of cells was analysed using GC. Cellular viability was determined by visual inspection of cells and lactate dehydrogenase release. DHA (400 μm) resulted in a significant 16 % reduction in IL-6 release after RV-43 infection, 29 % reduction in IL-6 release after RV-1B infection, 28 % reduction in IP-10 release after RV-43 infection and 23 % reduction in IP-10 release after RV-1B infection. Cellular DHA content negatively correlated with IL-6 and IP-10 release. None of the fatty acids significantly modified rhinovirus replication. DHA supplementation resulted in increased cellular content of DHA at the cost of AA, which may explain the decreased inflammatory response of cells. EPA and AA did not change the release of inflammatory biomarkers significantly. It is concluded that DHA has a potential role in suppressing RV-induced airway inflammation.


Sign in / Sign up

Export Citation Format

Share Document